News / Healthcare & pharma supply chains are 'fragile and infested with problems'

© Leowolfert

The Covid-19 pandemic has shone a harsh light, exposing vulnerabilities in healthcare and pharmaceutical supply chains.

The struggle to move limited supplies as fast as possible to meet rampant demand for test kits, personal protection equipment and drugs has been exacerbated by structural weaknesses.

A survey of more than 100 health experts, conducted just prior to the outbreak in the US and published this month by US Pharmacopeia and the MIT Center for Collective Intelligence, warns that medical supply chains remain vulnerable.

“New ...